Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	81665
Country	China

Received	2022-11-19 11:23
Peer-Review Started	2022-11-19 11:24
To Make the First Decision
Return for Revision	2022-12-25 18:36
Revised	2023-01-03 07:13
Second Decision	2023-02-02 03:26
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-02-02 13:02
Articles in Press	2023-02-02 13:02
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-02-07 06:44
Publish the Manuscript Online	2023-02-15 00:44

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Letter to the Editor
Article Title	Comment on “Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression”
Manuscript Source	Unsolicited Manuscript
All Author List	Jian Yang, Ying Liu and Shi Liu
Funding Agency and Grant Number
Corresponding Author	Shi Liu, PhD, Chief Physician, Central Laboratory, the Third Affiliated Hospital, Qiqihar Medical University, No. 27 Taishun Street, Tiefeng District, Qiqihar 161000, Heilongjiang Province, China. shiliu2199@163.com
Key Words	COVID-19; Pancreatic cancer; Lung–gut–pancreatic axis; Gut microbiota; Inflammatory factors; Immunotherapeutic
Core Tip	The coronavirus disease 2019 (COVID-19) pandemic has become a global burden, further exacerbating the occurrence of mortality risk events in patients with pancreatic cancer. The aim of this new article is to highlight the need for lung–gut–pancreatic axis-based studies with a focus on intra-axis microbiota crosstalk and potential mechanisms of association to address the severe survival challenges posed by the COVID-19 pandemic in patients with pancreatic cancer.
Publish Date	2023-02-15 00:44
Citation	Yang J, Liu Y, Liu S. Comment on “Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression”. World J Gastrointest Oncol 2023; 15(2): 368-371
URL	https://www.wjgnet.com/1948-5204/full/v15/i2/368.htm
DOI	https://dx.doi.org/10.4251/wjgo.v15.i2.368

Full Article (PDF)	WJGO-15-368.pdf
Full Article (Word)	WJGO-15-368.docx
Manuscript File	81665_Auto_Edited-LM.docx
Answering Reviewers	81665-Answering reviewers.pdf
Audio Core Tip	81665-Audio core tip.wav
Conflict-of-Interest Disclosure Form	81665-Conflict-of-interest statement.pdf
Copyright License Agreement	81665-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	81665-Language certificate.pdf
Peer-review Report	81665-Peer-review(s).pdf
Scientific Misconduct Check	81665-Bing Xing YX-2.png
Scientific Editor Work List	81665-Scientific editor work list.pdf
CrossCheck Report	81665-CrossCheck report.pdf